Eric Weisblum
Tracked across 5 events · 31 articles · First seen Jul 07, 2026 · Last active Sep 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: As CEO of Silo Pharma, Eric Weisblum announced the partnership, highlighting strategic expansion into AI. His leadership is key to executing the company's diversification strategy.
Jul 14, 2026 · 7 articles
Regulatory
Impact: As CEO of Silo Pharma, Eric Weisblum announced the patent grant and highlighted its strategic importance. His leadership is central to the company's IP strategy and communication with investors.
Aug 10, 2026 · 6 articles
Regulatory
Impact: Eric Weisblum, CEO of Silo Pharma, commented on the patent allowance, highlighting the company's momentum in securing international IP protection. His leadership is central to the company's strategy.
Aug 18, 2026 · 6 articles
Regulatory
Silo Pharma announced that the United States — United States Patent and Trademark Office issued a Notice of Allowance for a patent application covering its lead asset SPC-15, an investigational intranasal therapeutic being developed for…
Impact: Silo Pharma CEO Eric Weisblum commented on the strategic importance of the US patent protection for advancing SPC-15 development.
Sep 18, 2026 · 6 articles
Tech
Impact: As CEO of Silo Pharma, Weisblum announced the partnership, expressing optimism about the program's benefits for QwikAgents.
Jul 07, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Eric Weisblum live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard